Literature DB >> 2393409

Serum oestradiol in women with and without breast disease.

I C Bennett1, J F McCaffrey, E McCaffrey, B Wyatt.   

Abstract

It has been suggested that the percentage of non-protein-bound or free oestradiol (E2) is abnormally high in patients with breast cancer. In this study, the serum oestradiol profiles of a large group of women were analysed to determine whether a significant correlation could be found between serum oestradiol and various breast diseases. In addition oestradiol levels were measured in relation to sex hormone binding globulin (SHBG), albumin levels, oestrogen receptor status and family history of breast cancer. Serum samples were taken from a total of 300 women who had either no breast disease, benign breast disease or breast cancer. The percentage of free oestradiol was found to be highest in women with breast cancer, lowest in the control group and intermediate for the women with benign breast disease. These differences were most marked in post-menopausal women. The absolute values for total and free oestradiol were not statistically different in the three groups studied. There did not appear to be a correlation between oestrogen receptor (ER) concentration in breast cancer tissue and free E2 percentage levels. Women who had a family history of breast cancer did not appear to have higher percentage levels of free E2 than those with no such history. The presence of elevated proportions of free oestradiol in the serum of women with breast cancer may be significant in regard to understanding the aetiology of breast neoplasia. There also may be important implications for the use of this measurement in the earlier diagnosis and detection of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393409      PMCID: PMC1971338          DOI: 10.1038/bjc.1990.29

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Centrifugal ultrafiltration-dialysis for non-protein-bound oestradiol in blood: importance of the support.

Authors:  J W Moore; S A Hoare; M K Quinlan; G M Clark; D Y Wang
Journal:  J Steroid Biochem       Date:  1987-12       Impact factor: 4.292

Review 2.  Sex-hormone-binding globulin.

Authors:  D C Anderson
Journal:  Clin Endocrinol (Oxf)       Date:  1974-01       Impact factor: 3.478

3.  Oestrone sulphate, adipose tissue, and breast cancer.

Authors:  R A Hawkins; M L Thomson; E Killen
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

4.  Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens.

Authors:  V L Ernster; M R Wrensch; N L Petrakis; E B King; R Miike; J Murai; W H Goodson; P K Siiteri
Journal:  J Natl Cancer Inst       Date:  1987-11       Impact factor: 13.506

5.  Obesity, non-protein-bound estradiol levels, and distribution of estradiol in the sera of breast cancer patients.

Authors:  D M Ota; L A Jones; G L Jackson; P M Jackson; K Kemp; D Bauman
Journal:  Cancer       Date:  1986-02-01       Impact factor: 6.860

6.  Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease.

Authors:  M J Reed; R W Cheng; C T Noel; H A Dudley; V H James
Journal:  Cancer Res       Date:  1983-08       Impact factor: 12.701

7.  New automated dye-binding method for serum albumin determination with bromcresol purple.

Authors:  A E Pinnell; B E Northam
Journal:  Clin Chem       Date:  1978-01       Impact factor: 8.327

8.  Estrone sulfate: a potential source of estradiol in human breast cancer tissues.

Authors:  S J Santner; D Leszczynski; C Wright; A Manni; P D Feil; R J Santen
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

9.  Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk.

Authors:  P F Bruning; J M Bonfrèr; A A Hart
Journal:  Br J Cancer       Date:  1985-04       Impact factor: 7.640

  9 in total
  5 in total

1.  The relation of reported alcohol ingestion to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States).

Authors:  J F Dorgan; M E Reichman; J T Judd; C Brown; C Longcope; A Schatzkin; W S Campbell; C Franz; L Kahle; P R Taylor
Journal:  Cancer Causes Control       Date:  1994-01       Impact factor: 2.506

2.  Effect of Chinese medical herbs-Huiru Yizeng Yihao on hyperprolactinemia and hyperplasia of mammary gland in mice.

Authors:  Xiong Wang; Yong-Gang Chen; Li Ma; Zhi-Hui Li; Ju-Yi Li; Xin-Guo Liu; Ji-Li Zou; Jin-Hu Wu
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-05-16

3.  Factors associated with serum levels of estradiol and sex hormone-binding globulin among premenopausal Japanese women.

Authors:  C Nagata; N Kaneda; M Kabuto; H Shimizu
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

4.  Anti-Inflammatory Effect of a TCM Formula Li-Ru-Kang in Rats With Hyperplasia of Mammary Gland and the Underlying Biological Mechanisms.

Authors:  Yingying Wang; Shizhang Wei; Tian Gao; Yuxue Yang; Xiaohua Lu; Xuelin Zhou; Haotian Li; Tao Wang; Liqi Qian; Yanling Zhao; Wenjun Zou
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

5.  Therapeutic Effect of Mongolian Medicine RuXian-I on Hyperplasia of Mammary Gland Induced by Estrogen/Progesterone through CRYAB-Promoted Apoptosis.

Authors:  Jia Liu; Jun-Fei Zhang; Guo-Hua Gong; Bin Zhang; Cheng-Xi Wei
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-27       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.